People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TearScience, Inc. | — | Pharmaceuticals | Series B | $58.9M | $653.7M | 2010 |
Jim R. Largent at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jim R. Largent on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joel Cutler | 1 | 16 |
| Todd Davis | 1 | 8 |
| Immanuel Thangaraj | 1 | 6 |
| Joe Mandato | 1 | 5 |
| Geoff R. Pardo | 1 | 4 |
| Abhijeet Lele | 1 | 3 |
| Joe R. Mandato | 1 | 1 |
| Nicole R. Wicker | 1 | 1 |
| Manoj George | 1 | 1 |
| Joe Boorady | 1 | 1 |
| Matthew R. Rieke | 1 | 1 |
| Timothy R. Willis | 1 | 1 |
| Donald R. Korb | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.